Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia

ClinicalTrials.gov ID: NCT00073164

Public ClinicalTrials.gov record NCT00073164. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 2:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study of the Safety and Efficacy of Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the 14-day and 12-week safety and efficacy of Depakote ER used in combination with either olanzapine or risperidone versus antipsychotic monotherapy with olanzapine or risperidone for the treatment of schizophrenia.

Study identification

NCT ID
NCT00073164
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Abbott
Industry
Enrollment
400 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2003 (Type not available)
Primary completion
Not listed
Completion
Not listed
Last update posted
Aug 4, 2006

Started 2003

United States locations

U.S. sites
35
U.S. states
18
U.S. cities
35
Facility City State ZIP Site status
Not listed Birmingham Alabama — —
Not listed Tuscaloosa Alabama — —
Not listed Anaheim California — —
Not listed Cerritos California — —
Not listed Chula Vista California — —
Not listed Garden Grove California — —
Not listed Glendale California — —
Not listed Los Angeles California — —
Not listed San Diego California — —
Not listed Denver Colorado — —
Not listed Gainsville Florida — —
Not listed Melbourne Florida — —
Not listed North Miami Florida — —
Not listed Winter Park Florida — —
Not listed Atlanta Georgia — —
Not listed Chicago Illinois — —
Not listed Hoffman Estates Illinois — —
Not listed Indianapolis Indiana — —
Not listed South Bend Indiana — —
Not listed Shreveport Louisiana — —
Not listed Rockville Maryland — —
Not listed Jackson Mississippi — —
Not listed Clementon New Jersey — —
Not listed Kenilworth New Jersey — —
Not listed Holliswood New York — —
Not listed New York New York — —
Not listed Butner North Carolina — —
Not listed Cincinnati Ohio — —
Not listed Cleveland Ohio — —
Not listed Oklahoma City Oklahoma — —
Not listed Philadelphia Pennsylvania — —
Not listed Austin Texas — —
Not listed Irving Texas — —
Not listed San Antonio Texas — —
Not listed Falls Church Virginia — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00073164, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 4, 2006 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00073164 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →